Angioedema Treatment Market

Future Market Insights

Key Insight

The angioedema treatment market is projected to grow from USD 6.5 billion in 2025 to USD 30.3 billion by 2035, at a CAGR of 16.6%. Antihistamines will dominate with a 33.2% market share, while hospitals will lead the end use segment with a 52.3% share.

September 16, 2025

Anurag Sharma

250 Pages

Cite this Report

Angioedema Treatment Market

https://www.futuremarketinsights.com/reports/angioedema-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

BioCryst Pharmaceuticals
CSL Limited
Ionis Pharmaceuticals
Pharming Group NV
Shire plc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Angioedema Treatment Market

Key Players

Similar Industry Reports